Clinical trials Flashcards

1
Q

why don’t we like before and after studies

A

due to regression to the mean

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

regression to the mean

A

take most extreme populate with intervention and will always tend to regress to the mean

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

regression…. extended

A

reason people have joined the study [predisposed to an upswing
i.e. usually both arms of the trial will improve

e.g. someone with bad migraines- migraines ill tend to get better e.g. just by talkingg and being reassured by the doctor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

due to regression to the mean

A

we must be sceptical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

example of variable dependent variables

A

e. g. did have high bp, then goes down to normal at T2
- however someone from T1 with normal BP may have high BP at T2

-population stays the same, but people move in the population

due to upswings and downswings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

after new findings how long doe it take for clear, widespread practice to start in hospitals

A

17 years on average e.g. cortisone

however only 2 years for artificial surfactant- money and companies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why do we randomise

A

best way of making differences in baseline in groups only occur due to change
- want differences at baseline to be due to chance rather than systematic on one way or another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

randomisation means that

A

it is the manipulation of treatment which manipulates the data and not confounding variables

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

statistics help us with

A

chance differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

statistics do not help us with

A

systematic differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why manipulate data

A
  • a desire for a positive outcome
  • stop money feeling wasted
  • much more likely to get published in big journal
  • get famous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why is there a need for allocation concealment

A

if clinicians are part of the trial they may want to give their patients the active treatment- can be conscious or unconscious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

allocation concealment

A

around 30% diff in effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

getting the question right

A

i.e. if the study has addressed a male population, the results shouldn’t be extrapolate for females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

questions to answer

A

is the research valid?

is it applicable to the problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clinical problem vs study question

A

PICOs should match

17
Q

example PICO

A

P people who have snakebites in rural india, treated with anti-venom
I adrenaline, anti-venom
C antihistamine , steroid. Anti-venom along
O deaths, morbidity, mortality, cost

18
Q

randomisation involves

A

how allocation of groups occured

19
Q

what can be used to randomise

A

can be computer generated- no bas

20
Q

randomisation ensures that

A

differences in demographic groups are just due to chance and reduces ALLOCATION BIAS

21
Q

in clinical trial papers it is important to show

A

the extent where baseline characteristics int he two groups are similar
e.g. sex, age, species of snake, delay in admission to hospital, first aid, worst outcmes

22
Q

important to show baseline characterisitcs

A

so countries can see ow relevant data is for their populations- allow additional studies

23
Q

Follow up- complete and long-enough?

A
  • neurological evaluations?
  • Kept in hospital?
  • adverse reactions with graded criteria
  • monitored for 96h
  • long term check up?
24
Q

why are follow ups important to record

A

allows future researchers to know what possible adverse effects could be

25
Q

blinding

A

ensure both groups are treated the same

26
Q

why should we blind

A
  • clinicians- way change the way they manage patients
  • patients- placebo effect
  • researchers- outcome measurers- clearly objective
27
Q

stats cannot be used for

A

baseline variation

28
Q

what does a p value of 0.04 mean

A

if we did an infinite number of studies of this size 4% of the time we would get results like this more more extreme, if there was no difference

29
Q

what drives p value

A

sample size and variation